These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38507225)

  • 1. Understanding the paradigm.
    Okerberg C; Adie S; Konerman M; Zimmerman C
    Am J Health Syst Pharm; 2024 Jul; 81(15):e396-e397. PubMed ID: 38507225
    [No Abstract]   [Full Text] [Related]  

  • 2. The eligible population of the PARADIGM-HF trial in a real-world outpatient clinic and its cardiovascular risk between 2005 and 2016.
    Chen X; Schaufelberger M; Fu M
    J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):6-12. PubMed ID: 31789711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemonitoring in heart failure patients with clinical decision support to optimize medication doses based on guidelines.
    Kropf M; Modre-Osprian R; Hayn D; Fruhwald F; Schreier G
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():3168-71. PubMed ID: 25570663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
    Lee HY; Oh BH
    Int J Heart Fail; 2020 Jul; 2(3):145-156. PubMed ID: 36262366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of clinical decision support in reducing readmissions for patients with heart failure: a quasi-experimental study.
    Giscombe SR; Baptiste DL; Koirala B; Asano R; Commodore-Mensah Y
    Contemp Nurse; 2021; 57(1-2):39-50. PubMed ID: 33863268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan.
    Sokos GG; Raina A
    Vasc Health Risk Manag; 2020; 16():41-51. PubMed ID: 32021227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into implementation of sacubitril/valsartan into clinical practice.
    Martens P; Beliën H; Dupont M; Mullens W
    ESC Heart Fail; 2018 Jun; 5(3):275-283. PubMed ID: 29464879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is heart failure an abnormality of myocardial cell growth?
    Katz AM
    Cardiology; 1990; 77(5):346-56. PubMed ID: 2073654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of heart failure patients with reduced ejection fraction in the Moravian Midlands Registry with the LCZ696 patients in the Paradigm-HF trial.
    Pavlu L; Vicha M; Flasik J; Petrkova J; Taborsky M; Kacirkova T; Holy O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Sep; 168(3):229-234. PubMed ID: 36748670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.
    Książczyk M; Lelonek M
    Heart Fail Rev; 2020 May; 25(3):393-402. PubMed ID: 31713710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A broader paradigm for understanding and treating heart failure.
    Havranek EP; Masoudi FA; Rumsfeld JS; Steiner JF
    J Card Fail; 2003 Apr; 9(2):147-52. PubMed ID: 12751136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.
    Kapelios CJ; Lainscak M; Savarese G; Laroche C; Seferovic P; Ruschitzka F; Coats A; Anker SD; Crespo-Leiro MG; Filippatos G; Piepoli MF; Rosano G; Zanolla L; Aguiar C; Murin J; Leszek P; McDonagh T; Maggioni AP; Lund LH;
    Eur J Heart Fail; 2019 Nov; 21(11):1383-1397. PubMed ID: 31132222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Clinician Macrocognition to Inform the Design of a Congenital Heart Disease Clinical Decision Support System.
    Assadi A; Laussen PC; Freire G; Trbovich P
    Front Cardiovasc Med; 2022; 9():767378. PubMed ID: 35187118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Decision-Making for Heart Failure in Kosovo: A Conjoint Analysis.
    Hoxha I; Guda B; Hoti A; Zhubi E; Selmani E; Avdiu B; Cegllar J; Marušič D; Osmani A
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design.
    Tait L; Roalfe AK; Mant J; Cowie MR; Deeks JJ; Iles R; Barton PM; Taylor CJ; Derit M; Hobbs FD
    BMC Cardiovasc Disord; 2012 Oct; 12():97. PubMed ID: 23110558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on the Genetic Paradigm in Heart Failure.
    Rosenbaum AN; Pereira N
    Curr Treat Options Cardiovasc Med; 2019 Jun; 21(8):37. PubMed ID: 31250202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of self-care decision-making in hospitalised patients with heart failure.
    Tsai PK; Wang RH; Lee CS; Tsai LM; Chen HM
    J Clin Nurs; 2015 Apr; 24(7-8):1101-11. PubMed ID: 25363594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Centered Clinical Trial Design for Heart Failure Devices via Bayesian Decision Analysis.
    Chaudhuri SE; Adamson P; Bruhn-Ding D; Ben Chaouch Z; Gebben D; Rincon-Gonzalez L; Liden B; Reed SD; Saha A; Schaber D; Stein K; Tarver ME; Lo AW
    Patient; 2023 Jul; 16(4):359-369. PubMed ID: 37076697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conceptual paradigm of heart failure and systems biology approach.
    Louridas GE; Lourida KG
    Int J Cardiol; 2012 Aug; 159(1):5-13. PubMed ID: 21794935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.